Furthermore, we observed that treatment with D2R agonist quinpirole significantly reduced the expression of PD-L1 on the surface of cells from the JHU-LX33R SCLC PDX organoids relative to treatment with control vehicle (Supplementary Fig. 8). This evidence concerns the gene DRD2 and small cell lung carcinoma.